COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Ankle Equinus Contracture Treated With Dynamic Splinting

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01238484
Recruitment Status : Terminated (Centers could not meet enrollment goals)
First Posted : November 10, 2010
Last Update Posted : July 11, 2013
McMurry University
Information provided by (Responsible Party):
Dynasplint Systems, Inc.

Brief Summary:
The purpose of this study is to determine if the Ankle Dorsiflexion Dynasplint System (DS) is effective in treating contracture for patients with Ankle Equinus secondary to diabetes mellitus.

Condition or disease Intervention/treatment Phase
Ankle Equinus Ankle Contracture Diabetes Mellitus Other: Standard of care Device: Dynasplint Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Ankle Equinus Contracture Treated With Dynamic Splinting in a Randomized, Controlled Trial
Study Start Date : August 2010
Actual Primary Completion Date : January 2013
Actual Study Completion Date : January 2013

Arm Intervention/treatment
Active Comparator: Control
Patients in the control group will be treated with the current standard of care including shoe modification and home stretching exercises.
Other: Standard of care
shoe modification home stretching exercises

Experimental: Experimental
Patients assigned to the experimental group will receive the current standard of care as well as the Ankle Dorsiflexion Dynasplint.
Device: Dynasplint
shoe modification home stretching exercises Ankle Dorsiflexion Dynasplint

Primary Outcome Measures :
  1. Range of Motion [ Time Frame: 4 months ]
    The primary outcome is change in ankle range of motion

Secondary Outcome Measures :
  1. Pain [ Time Frame: 4 months ]
    The secondary outcome will be change in pain scale rating as reported by patient

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Previous Diagnosis Diabetes Mellitus
  • Reduced flexibility in AROM of extension in the ankle
  • Less than 10º Maximal, Active Dorsiflexion, while upright
  • Impaired gait pattern

Exclusion Criteria:

  • Previous surgical treatment for this pathology
  • Previous surgery of the Achilles tendon or triceps surae
  • Current treatment with corticosteroids
  • Current treatment with Botulinium Toxin-A (Botox), lower extremity
  • Current treatment Fluoroquinolones (antibiotic medication)
  • Current use of muscle relaxant medications
  • Fibromyalgia
  • Stroke, CVA, Brain Injury, Spinal Cord Injury, or any neural pathology causing plasticity or hypertonicity
  • Current participation in manual, physical therapy
  • Treatment with electrical stimulation assisting ambulation (i.e. Bioness, WalkAide, Parastep, etc.)
  • Preexisting open sores on foot or leg

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01238484

Layout table for location information
United States, Georgia
Atlanta Foot and Leg Clinic
Jonesboro, Georgia, United States, 30236
United States, Texas
Lopez Ankle and Foot
Fort Worth, Texas, United States, 76164
Sponsors and Collaborators
Dynasplint Systems, Inc.
McMurry University
Lopez AA, Kalish SR, John MM, Willis FB. Reduction of Ankle Equinus Contracture Secondary to Diabetes Mellitus with Dynamic Splinting. Foot & Ankle Online Journal. 2010 3(3):13-18
Lai J, Jones M, Willis B. Effect of Dynamic Splinting on Excessive Plantar Flexion Tone/Contracture: A Controlled, Cross-Over study. Proceedings of the 16th European Congress of Physical and Rehabilitation Medicine. Minerva Medica pubs, Italy, August 2008, pg 106-109.
Kalish SA, Willis FB. Hallux Limitus and Dynamic Splinting: a Retrospective Series. The Foot & Ankle Online Journal 2009 Apl;2(4),1

Layout table for additonal information
Responsible Party: Dynasplint Systems, Inc. Identifier: NCT01238484    
Other Study ID Numbers: 2010:004
First Posted: November 10, 2010    Key Record Dates
Last Update Posted: July 11, 2013
Last Verified: July 2013
Keywords provided by Dynasplint Systems, Inc.:
Ankle Equinus
Ankle contracture
Diabetes Mellitus
Additional relevant MeSH terms:
Layout table for MeSH terms
Equinus Deformity
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Joint Diseases
Musculoskeletal Diseases
Muscular Diseases
Foot Deformities, Acquired
Foot Deformities
Foot Deformities, Congenital
Lower Extremity Deformities, Congenital
Limb Deformities, Congenital
Musculoskeletal Abnormalities
Congenital Abnormalities